Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Morrison Foerster Recognized by Law Society of Hong Kong with Gold Law Firm Award

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

The Law Society of Hong Kong has once again honored Morrison Foerster with the Gold Law Firm Award as part of its 2025 Pro Bono...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

The Law Society of Hong Kong has once again honored Morrison Foerster with the Gold Law Firm Award as part of its 2025 Pro Bono and Community Work Recognition Programme. MoFo is one of only 13 law firms in Hong Kong that met the threshold for the Gold Law Firm Award, which is based on the number of pro bono hours contributed by lawyers in the office. During 2025, the firm’s lawyers in Hong Kong devoted more than 3,000 hours to pro bono legal representation, demonstrating the firm’s outstanding commitment to pro bono and community work.At the individual level, 26 lawyers from MoFo received recognition for their continued pro bono efforts, including:<ul><li>Julia Lee, Associate – Gold</li><li>Ferdinand Loo, Associate – Gold</li><li>Katrina Tsoi, Associate – Gold</li><li>Nicole Tsui, Associate – Gold</li><li>Laetitia Yuen, Trainee Solicitor – Gold</li><li>Stephen Birkett, Partner – Silver and Improvement Award</li><li>Timothy Blakely, Co-Managing Partner – Silver and Improvement Award</li><li>Zooey Chen, Associate – Silver</li><li>Gigi Yuen, Of Counsel – Silver</li><li>Bryan Lam, Associate – Silver</li><li>Winnie Lam, Associate – Silver</li><li>Matthew Lau, Partner – Silver and Improvement Award</li><li>Yilong Luo, Associate – Silver and Improvement Award</li><li>Ziqi Qi, Associate – Silver</li><li>Gary Zeng, Of Counsel – Silver</li><li>Yiman Zhang, Associate – Silver and Improvement Award</li><li>Daniel Chan, Trainee Solicitor – Bronze</li><li>Sylvia Cheng, Associate – Bronze</li><li>Marcia Ellis, Partner – Bronze</li><li>Harriet Ho, Associate (pending admission) – Bronze</li><li>Kristen Lai, Associate (pending admission) – Bronze</li><li>Nicholas Li, Trainee Solicitor – Bronze</li><li>Paul McKenzie, Partner – Bronze</li><li>Liam Shao, Associate (pending admission) – Bronze</li><li>Tyler Xiu, Of Counsel – Bronze</li><li>Shuwen Zeng, Associate – Bronze</li></ul>Lawyers at Morrison Foerster live out the firm’s proud pro bono tradition every day. Their work runs the gamut, from counseling hundreds of nonprofit organizations and social enterprises on legal needs to individual advocacy for people who otherwise would be shut out from access to justice. View more information on our <a href="/culture/pro-bono" target="_self">Pro Bono</a> page.

Morrison Foerster Recognized by Law Society of Hong Kong with Gold Law Firm Award

Sign Up

Julia’s practice spans across cross-border M&A, joint ventures, as well as private equity.Prior to joining Morrison & Foerster, Julia was an associate in the Hong Kong office of a major international law firm.Julia is fluent in English, Cantonese, and Mandarin.

李恺宜律师业务涵盖跨境并购、合资公司及私募股权。在加入美富前，李律师曾在某领先的国际法律事务所的香港办事处担任律师。李律师精通英语、粤语及普通话。

Julia Lee

Associate

Ferdinand’s practice focuses on private equity transactions, mergers and acquisitions, venture capital financings, as well as other general corporate matters.Ferdinand received his J.D. and P.C.LL. from the Chinese University of Hong Kong in 2019 and 2020, respectively, where he was placed on the Dean’s List, named a Silver Scholar and received the Gallant Ho Prize in Law.Ferdinand is fluent in English, Cantonese and Mandarin.<h4>Representative Matters</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>Six Waves Inc., a leading global publisher of mobile games based in Hong Kong, in its US$201 million acquisition by Stillfront Group AB (publ), a Sweden-based powerhouse of gaming studios listed on Nasdaq Stockholm.</li><li>LSE-listed Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions, in connection with its acquisition of Quantum Hi-Tech (Guangdong) Biological Co., Ltd, a leading probiotic dietary fiber business in China, from ChemPartner Pharmatech Co., Ltd.</li><li>A private equity investment management firm in its EUR180 million leveraged buyout of a Hong Kong-based private industrial company and its subsidiaries.</li><li>A multinational conglomerate holding company on its restructuring of a PRC asset valued at US$930 million.</li><li>A leading global real estate logistics provider in its restructuring of assets valued at US$480 million.</li></ul>

卢晖洋律师的执业领域主要为私募投资交易、并购、风险投资融资以及其他一般公司事宜。卢律师分别于2019和2020年获得香港中文大学法律博士学位和法学专业证书。在求学期间，他荣登“院长嘉许名单(Dean’s List)”，并荣获“银奖学者(Silver Scholar)”称号和“何耀棣法学成绩优异奖”。卢律师精通英语、普通话和粤语。<h4>具代表性的交易项目</h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>代表总部位于香港的全球领先手游发行商Six Waves Inc.处理其被纳斯达克斯德哥尔摩上市的瑞典游戏工作室巨头Stillfront Group AB (publ)以2.01 亿美元收购的事宜。</li><li>代表在伦敦证券交易所上市的泰莱集团(Tate & Lyle PLC)处理其从睿智医药股份有限公司协议收购其旗下量子高科（广东）生物有限公司的事宜。</li><li>代表一家私募股权投资管理公司处理其以1.8亿欧元通过杠杆方式收购一家香港私有工业公司及其子公司的事宜。</li><li>代表一家跨国企业集团控股公司处理其9.3亿美元中国资产的重组事宜。</li><li>代表一家领先的全球房地产物流供应商处理其4.8亿美元资产重组的事宜。</li></ul>

Ferdinand Loo

Katrina’s practice focuses on a diverse range of corporate matters, including cross-border mergers and acquisitions, private equity investments, regulatory and compliance, and other general corporate matters.Katrina has experience advising multinational companies, sovereign wealth funds, private equity investors, family offices, and start up entrepreneurs across various sectors including consumer goods and services, life sciences, and technology (including AgTech).Katrina is fluent in English, Cantonese and Mandarin.<h4>Representative Matters</h4><ul><li>Happiness Capital</li><ul><li>in its US$350,000 Series Seed investment in Kyomei, a company with innovative molecular farming technology to use plants to produce animal-identical proteins that replicate the taste and nutritional value of traditional meat.</li><li>in connection with the US$10 million Series A minority investment in Botrista, a U.S.-based robotic barista automation solution provider.</li><li>in connection with the US$4.7 million equity investment in NovoNutrients, a U.S.-based alternative proteins company that transforms CO2 emissions into high-value, low-cost proteins and additives for food and feed.</li></ul><li>Cayman Islands-incorporated and Taiwan-based The News Lens Co., Ltd. (TNL) in its proposed de-SPAC with Blue Ocean Acquisition Corporation (NASDAQ: BOCN), a publicly traded special purpose acquisition company, and its proposed listing on NASDAQ.  TNL is an independently owned international web media group with editions of its core “The News Lens” brand published in Taiwan, Hong Kong, ASEAN and Japan as well as an International (English) edition. </li><li>Ally Bridge Group in connection with numerous investments in various life sciences companies, including: </li><ul><li>as lead investor in connection with the US$60 million Series F financing of Aerin Medical Inc., a medical technology company focused on the ear, nose and throat market providing non-invasive solutions for the treatment of chronic nasal conditions.</li><li>as lead investor in connection with the US$62 million Series D financing of Mission Bio, Inc., a life science tools company focused on single cell genomics, proteomics and multi-omics solutions for oncology study and cell and gene therapy development.</li><li>as lead investor in connection with the $101 million Series B financing of Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis.</li><li>as lead investor in connection with an oversubscribed US$265 Million Series B financing of Sonoma Biotherapeutics, a U.S. based life sciences company developing treatments for autoimmune and degenerative disease.</li><li>in the follow-on US$100 million Series D financing of a company with a subscription-based application that connects patients with professional health coaches, nutritionists, exercise physiologists, nurses, and diabetes educators. </li><li>in a follow-on US$81 million equity investment in Rapid Micro Biosystems, Inc., a U.S. based medical product manufacturer. Including this latest financing, Rapid Micro Biosystems has raised over $340 million of equity for its expansion.</li><li>in connection with the $200 million Series C investment of Transcarent, a new and different health and care experience company for employees of self-insured employers and their families.</li></ul><li>LeapXpert, a Hong Kong and US-based communications and messaging platform provider, in connection with its US$22 million Series A+ financing led by Rockefeller Asset Management. The investment also includes participation from Uncorrelated Ventures, the Partnership Fund for New York City, and a new strategic investor, as well as existing investors.</li></ul><ul><li>Tencent Holdings Limited its US$46 million (JPY5 billion) acquisition of a majority stake in Wake Up Interactive Limited, together with its wholly-owned subsidiaries in Japan, Valhalla Game Studios Ltd. and Soleil Ltd., which produce video games and online entertainment. </li><li>LSE-listed Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions,<ul><li>in connection with its agreement to acquire Quantum Hi-Tech (Guangdong) Biological Co., Ltd, a leading prebiotic dietary fiber business in China, from ChemPartner Pharmatech Co., Ltd.</li><li>on its acquisition of Sweet Green Fields (SGF), a leading global stevia solutions business.</li></ul></li><li>Ping An Insurance (Group) Company of China Ltd. in its capital and strategic alliance with Shionogi & Co., Ltd. with a total value of US$780 million, which includes (i) subscription of a 2.05% voting stake in Shionogi and (ii) establishment of joint ventures in Shanghai and Hong Kong. Shionogi is a leading research-driven pharmaceutical company headquartered in Japan.</li><li>Ascendent Automation (Cayman) Limited, an affiliate of Ascendent Capital Partners as one of the Joint Offerors, in its offer to privatize China Automation Group Limited (CAG) (0569.HK) by way of a Cayman scheme of arrangement for HK$391,998,649.50 (about US$50.06 million). Ascendent Capital Partners also provided a loan facility to the other joint offeror (being the controlling shareholder of CAG) for the purpose of the offer. CAG is a China-based company principally engaged in: (i) the provision of safety and critical control system and control valves specialized for petrochemical industries, along with related maintenance and engineering services; and (ii) hospital business in Suzhou, the PRC.</li><li>SoftBank Vision Fund in connection with an investment totaling US$1.5 billion in Chehaoduo, a leading Chinese customer-to-customer auto retail services company that operates Guazi, an e-commerce platform focusing on second-hand car transactions, and Maodou, an e-commerce platform focusing on new car transactions.</li></ul>

蔡嘉莉律师的执业领域侧重于各类公司事宜，包括跨境并购、私募股权投资、监管与合规，以及其他一般公司事宜。蔡律师在为跨国公司、主权财富基金、私募股权投资者、家族办公室和初创企业家提供法律意见方面经验丰富，客户涉及消费品和服务、生命科学和技术（包括农业技术）等多个领域。蔡律师精通英语、粤语和普通话。<h4>具有代表性的交易</h4><ul><li>代表Happiness Capital 处理一系列投融资事宜，包括</li></ul><ul><li>处理其对 Kyomei 公司进行的 35万美元的种子轮投资事宜，该公司拥有创新的分子农业技术，可利用植物生产与动物相同的蛋白质，从而复制传统肉类的味道和营养价值。</li><li>处理对Botrista的A轮与B轮股权投资事宜。Botrista是一家位于美国的为混合饮料提供自动化解决方案的跨国机器人公司。</li><li>处理对NovoNutrients的470万美元股权投资事宜。NovoNutrients是美国一家替代蛋白公司，可将二氧化碳排放物转化为高价值、低成本的蛋白质及食品和饲料添加剂。</li></ul><ul><li>代表在开曼群岛注册、总部设在台湾的The News Lens Co., Ltd. (TNL)处理其与纳斯达克上市的特殊目的收购公司Blue Ocean Acquisition Corporation (NASDAQ: BOCN) 的合并以及其在纳斯达克上市的事宜。TNL是一家独立的国际网络媒体集团，其核心品牌“关键评论网“( "The News Lens ")在台湾、香港、东盟和日本运营，并拥有国际英文版。</li><li>代表软银集团公司和软银愿景基金处理其拟以650亿美元将Arm Limited出售给美国领先的芯片公司NVIDIA（纳斯达克股票代码：NVDA）的事宜。Arm Limited是一家总部位于英国的跨国半导体和软件设计公司。</li></ul><ul><li>代表汇桥资本处理一系列投融资事宜，包括</li><ul><li>作为牵头投资人处理其对Aerin Medical Inc.规模为6000 万美元的F轮融资事宜。Aerin Medical是一家专注于耳鼻喉市场的医疗技术公司，为慢性鼻腔疾病的治疗提供非侵入性解决方案。</li><li>作为牵头投资人处理其对Mission Bio Inc.规模为6200 万美元的D轮融资事宜。Mission Bio是一家生命科学工具公司，专注于单细胞基因组学、蛋白质组学和多组学解决方案肿瘤学研究以及细胞和基因疗法。</li><li>作为牵头投资者处理Endeavor BioMdicines的01亿美元B轮融资事宜。Endeavor BioMedicines是一家处于临床阶段的生物技术公司，主要针对肿瘤和纤维化等绝症的核心驱动因素。</li><li>作为领投方处理Sonoma Biotherapeutics获超额认购的65亿美元B轮融资事宜。该公司是一家美国生物科技公司，致力于开发自体免疫性和退行性疾病的治疗方法。</li><li>处理一家基于订购的虚拟医疗保健公司的后续1亿美元D轮融资事宜。该公司将患者与专业的健康教练、营养师、运动生理学家、护士和糖尿病教育者联系起来。</li><li>处理美国医疗产品制造商Rapid Micro Biosystems, Inc.的8100万美元后续股权投资事宜。包括此次最新轮融资在内，Rapid Micro Biosystems已经为其扩张筹集了超过4亿美元。</li><li>处理Transcarent公司的2亿美元C轮投资事宜。Transcarent面向自保雇主的雇员及其家人提供新型且与众不同的健康和护理体验。</li></ul></ul><ul><li>代表总部位于香港和美国的通信和信息平台供应商LeapXpert就其$2200万美元的A+轮融资提供咨询服务，该轮融资由洛克菲勒资产管理公司(Rockefeller Asset Management)牵头。该项投资的参与者还包括Uncorrelated Ventures、纽约市合伙基金和一名新的战略投资者，以及现有投资者。</li></ul><ul><li>代表腾讯处理其以 4600 万美元（50 亿日元）收购 Wake Up Interactive Limited 及其在日全资子公司 Valhalla Game Studios Ltd. 和 Soleil Ltd. 的多数股权事宜。Wake Up Interactive是日本一家创意游戏公司，从事视频游戏和网络游戏开发。 </li></ul><ul><li>代表在伦敦证券交易所上市的领先的全球食品和饮料原料及解决方案提供商泰莱集团(Tate & Lyle PLC)</li><ul><li>处理其从睿智医药股份有限公司协议收购其旗下量子高科（广东）生物有限公司的事宜。</li><li>处理其收购领先的全球甜菊糖供应商Sweet Green Fields (SGF)的事宜。</li></ul></ul><ul><li>代表中国平安保险（集团）股份有限公司处理其与盐野义制药株式会社高达7.8亿美元的资本与战略联盟的事宜，当中涉及(i) 认购盐野义的2.05%具表决权股份，及(ii) 于上海及香港分别设立合资公司。盐野义为一家总部设于日本的领先的研究型医药公司。</li><li>代表Ascendent Automation (Cayman) Limited（上达资本的全资子公司）作为联合要约人之一处理其对中国自动化集团有限公司（香港股份代号：0569）规模为391,998,649.50港元（约5,006万美元）的私有化安排。上达资本还为作为中国自动化集团有限公司控股股东的联合要约人提供贷款。中国自动化集团是一家总部位于中国的公司，主要从事的业务包括：（i）提供专门用于石化行业的安全及紧急控制系统及安全阀，以及相关之保养及工程服务；（ii）位于中国苏州的医院相关业务。</li><li>代表软银愿景基金处理其对车好多集团总计15亿美元的投资。车好多是中国领先的汽车直卖平台，旗下主要包含瓜子二手车直卖网（主要经营二手车交易）和毛豆新车网（主要经营新车交易）两大平台。</li></ul>

Katrina Tsoi

Nicole Tsui is a litigation associate in Morrison Foerster’s Hong Kong Office.Her practice focuses on litigation and international arbitration matters on behalf of both local and multinational clients. She has experience in handling complex arbitration disputes in a wide range of industries, including shipping, construction, commodities and finance under the arbitration rules of major institutions such as the International Chamber of Commerce (ICC), the United Nations Commission on International Trade Law (UNCITRAL), Hong Kong International Arbitration Centre (HKIAC) and London Maritime Arbitrators Association (LMAA). She has also handled various court proceedings before Hong Kong courts.Nicole is fluent in English, Cantonese and Mandarin.

徐晞彤是美富律师事务所香港办事处诉讼业务部的律师。徐律师主要代表本地及国际客户处理诉讼及国际仲裁事宜。她曾为包括航运、建造、商品及金融等在内的多个行业的客户处理多宗复杂仲裁争议，涉及多个重要仲裁机构规则，包括国际商会（ICC）、联合国国际贸易法委员会（UNCITRAL）、香港国际仲裁中心（HKIAC）及伦敦海事仲裁员协会（LMAA）等。徐律师也曾处理各种香港法院程序。徐律师通晓英语、广东话及普通话。

Nicole Tsui

Stephen Birkett is a Senior of Counsel at the firm and a Partner in our Hong Kong office.Stephen has practiced in Hong Kong for over 25 years and specializes in capital markets advisory and transactional matters, regulatory issues, and mergers and acquisitions transactions. His experience includes advising on the Hong Kong Stock Exchange Listing Rules, including numerous IPOs, and the Hong Kong Takeovers Code, as well as corporate and securities law and regulations generally. This includes advising clients on SFC licensing issues for intermediaries, non-contentious employment matters, and general commercial transactions.He recently advised a securities fintech business licensed by the SFC and which offers a Chinese language app for trading equities in select international markets on SFC compliance issues.Prior to joining Morrison & Foerster, Stephen served for three years as Senior Director of Corporate Finance with the Securities and Futures Commission in Hong Kong. Before that, he was a partner and Head of Corporate Finance in a leading international firm in Hong Kong. He was a member of the Hong Kong Government Standing Committee on Company Law Reform from 2011 until the end of his six-year tenure.Stephen is a frequent speaker at conferences on Hong Kong securities legal issues and has authored chapters on the Hong Kong Takeovers Code and Listing Rules in the popular “Practitioner’s Guide” series.Stephen is fluent in French and Spanish.

白士文律师在香港的执业时间已超过25年，专门处理资本市场咨询和交易事宜、监管问题以及并购交易。他的经验包括就《香港联交所上市规则》提供法律意见，其中涉及多次首次公开发行、《香港收购守则》以及一般公司及证券法律法规事宜。他曾就中间机构获取证监会牌照事宜、无争议性雇佣事宜以及一般商业交易提供法律意见。在加入美富之前，白律师担任香港证券及期货事务监察委员会（证监会）的高级董事三年。之前亦曾经担任香港一家具领导地位的国际律师事务所的合伙人及企业融资部门主管。白律师从2011年起出任香港公司法改革常务委员会的成员，直至其六年任期期满为止。白律师经常就香港证券的法律问题发表演说，并且曾经撰写广受欢迎的“执业者指引”（Practitioner’s Guide）系列中有关《香港收购守则》及《上巿规则》的章节。白律师精通法语和西班牙语。

Stephen Birkett

Solicitor

Tim is a partner in Morrison Foerster’s Securities Litigation and Investigations + White Collar Defense groups. His practice focuses on government and internal investigations and complex commercial litigation and international arbitration matters. He is the former managing partner of the Hong Kong office.With more than 20 years of experience in the U.S. and Asia, Tim represents companies and individuals in complex dispute-related matters, including government and internal investigations, regulatory proceedings, securities class action lawsuits, international arbitrations, and other complex litigation mandates. He has represented multinational and Chinese clients in various industries, including telecommunications, biotechnology, publishing, pharmaceuticals, and financial services. Tim is a member of the firm’s FCPA + Global Anti-Corruption and Global Ethics + Compliance teams. Tim has practiced in New York, California, and Hong Kong, handling fraud, misrepresentation, breach of contract, securities litigation, investment disputes, commercial arbitration, and enforcement-related matters – from inception through trial. His practice has a strong U.S. and Asia nexus, and he regularly advises clients facing cross-border disputes and enforcement actions, often involving the laws of multiple jurisdictions.As a Hong Kong solicitor, Tim has been instructed by clients in key contentious proceedings and arbitration-related matters before Hong Kong courts (including the Court of First Instance, the Court of Appeal, and the Court of Final Appeal), as well in proceedings with Hong Kong regulators and statutory tribunals. He has advised clients in investigations by Hong Kong law enforcement regulators including the Securities & Futures Commission and the Customs & Excise Department, among others. He regularly acts for clients in Hong Kong-seated international arbitration proceedings.

Timothy Blakely律师是美富律师事务所证券诉讼与调查以及白领犯罪辩护业务组的合伙人。他的执业领域主要专注于政府调查和内部调查，以及复杂商业诉讼和国际仲裁事务。他曾担任香港办公室的管理合伙人。Blakely律师在美国及亚洲拥有超过20年的执业经验，代表公司及个人处理各类复杂争议相关事宜，包括政府及内部调查、监管程序、证券集体诉讼、国际仲裁及其他复杂诉讼事务。他曾为来自电信、生物技术、出版、医药及金融服务等多个行业的跨国公司及中国客户提供法律服务。Blakely律师亦是本所美国《反海外腐败法》（FCPA）及全球反腐败工作组，以及全球道德与合规工作组的成员。Blakely律师曾在纽约、加州及香港执业，处理欺诈、不实陈述、合同违约、证券诉讼、投资争议、商业仲裁及执行相关事宜，其工作贯穿案件从初始阶段至审判全过程。他的执业实践与美国及亚洲均有紧密联系，经常就涉及多个司法管辖区法律的跨境争议及执法行动向客户提供法律意见。作为一名拥有香港事务资格的律师，Blakely律师曾受客户委托，在香港各级法院（包括原讼法庭、上诉法庭及终审法院）处理重要争讼程序及仲裁相关事宜，并代表客户在香港监管机构及法定特别法庭处理相关程序。他曾就香港执法及监管机构（包括证券及期货事务监察委员会及香港海关等）所进行的调查向客户提供法律意见，并经常代表客户处理以香港为仲裁地的国际仲裁程序。

Timothy Blakely

Partner

Zhiyu (Zooey)’s practice focuses on technology transactions, data privacy, and regulatory compliance advisory work. She has experience performing due diligence on data, cybersecurity, and intellectual property issues in M&A and private equity investments.Prior to joining Morrison Foerster, Zooey was a trainee solicitor in the London and Hong Kong offices of a leading international law firm.Zooey is a Registered Foreign Lawyer with the Law Society of Hong Kong. She is native in Mandarin and fluent in English.<h4>Representative Experience</h4><ul><li>A leading Singapore-based investment management company on its investment in a leading data-based searching company in China.</li><li>A leading online payment platform on its data processing, privacy policies, and personal information protection issues.</li><li>A Chinese state-owned telecommunications enterprise on its potential risk control issues in relation to the GDPR.</li><li>A leading multinational hospitality group on its responses to regulators in Asia (Hong Kong, Australia, Japan, Korea, and PRC) in relation to its data breaches investigations.</li><li>Leading multinational automotive manufacturing companies on various PRC law issues in relation to its automated driving systems, radio equipment and other in-car information services.</li></ul>*Including work performed at prior firms.

陈志瑜律师的执业领域主要是针对技术交易、数据隐私和监管合规事宜提供法律意见。她在就并购和私募股权投资项目中所涉及的数据、网络安全和知识产权问题开展尽职调查方面拥有丰富的经验。在加入美富之前，陈律师是一家领先的国际律所伦敦和香港办事处的实习律师。陈律师通晓普通话和英语。她是香港律师会注册外国律师。<h4>具有代表性的交易</h4><ul><li>一家领先的新加坡投资管理公司处理其向一家领先的中国数据检索公司进行投资事宜。</li><li>一家领先的在线支付平台处理数据处理、隐私政策以及个人信息保护问题。</li><li>一家中国国有电信企业处理与《通用数据保护条例》有关的潜在风险控制问题。</li><li>一家领先的跨国酒店集团处理针对数据违约调查事宜向亚洲国家及地区（包括香港、澳大利亚、日本、韩国和中国）监管机构做出响应。</li><li>领先的跨国汽车制造公司处理与自动驾驶系统、无线电设备和其他车内信息服务有关的各种中国法律问题。</li></ul>*包括在之前律所开展的工作

Zooey Chen

Gigi’s practice focuses on technology transactions, data privacy, and regulatory compliance advisory work across various industries. She has significant experience with private cross-border M&A and private equity investments. Gigi also has extensive knowledge of cross-border commercial technology transactions. She has worked with clients on a variety of projects from traditional technology transfer arrangements to complex collaborative development relationships. She has provided specialist operational technology law advice to clients in Greater China and Asia.Gigi handles all types of data advisory work across Greater China. She regularly advises clients on cutting-edge technology and IP regulatory matters covering data privacy, data security, data localization, cross-border data transfer, cybersecurity, and fintech.Prior to joining Morrison Foerster, Gigi was an associate in the Hong Kong office of a major international law firm.Gigi is fluent in English, Cantonese, and Mandarin.<h4>Representative Experience:</h4><ul><li>An NYSE-listed U.S. video game engine company in connection with<ul><li>Establishment and operation through a leading Chinese online partner of PRC-based cloud services for development studio customers in China; and</li><li>Establishment of a joint venture with multiple Tier 1 Chinese Internet technology companies to create, develop, and roll out a China-specific platform and ecosystem based on the client’s industry-leading products, technologies, and online services.</li></ul></li><li>A U.S. multinational consumer technology company with respect to its international payment network, including advising on regulatory requirements in Hong Kong and Macau, and issues pertaining to stored value card use of NFT wallets in metro transport systems.</li><li>The venture arm of an international payment network with respect to strategic investments in<ul><li>Early stage fintech companies, including a B2B and B2C SaaS platform for tax processing and payment in Singapore; </li><li>An open finance tech platform providing solutions for financial institutions in Southeast Asia (SEA); and</li><li>An Indonesian B2C travel services platform operating throughout SEA.</li></ul></li><li>A leading Chinese Internet services company in multiple debt and equity financings of a securities fintech business licensed by the SFC and which offers a Chinese language app for trading equities in select international markets.</li><li>A number of multinationals in various industries including technology, consumer health, and hospitality on data privacy and regulatory issues.</li></ul>

袁律师的业务重点为多个行业的技术交易、数据隐私及合规工作。她在处理非上市公司跨境并购和私募股权投资方面亦拥有丰富经验。袁律师还深谙跨境商业性技术交易。她曾协助客户处理过各种项目，从传统的技术转让安排到复杂的协同开发关系，并曾向大中华区和亚洲的客户提供专业的运营技术法律服务。袁律师在大中华区各地处理各种数据咨询工作。她经常就涵盖数据隐私、数据安全、数据本地化、跨境数据传输、网络安全和金融科技等的前沿技术和知识产权监管事宜向客户提供法律服务。<h4>具有代表性的项目：</h4><ul><li>代表某在纽交所上市的美国视频游戏引擎公司<ul><li>处理其通过中国领先的在线合作伙伴，为在中国开拓工作室客户设立和运营基于中国的云服务相关事宜。</li><li> 处理其与多家中国一级的科技互联网公司成立合资企业的事宜，以客户行业领先的产品、技术和在线服务为基础，创建、开发和推出中国特有的平台和生态系统。</li></ul></li><li> 代表一家美国跨国消费技术公司处理其国际支付网络的相关事宜，包括就香港和澳门的监管要求以及在储值卡、地铁运输系统中使用 NFT 钱包有关的问题提供法律服务。</li><li> 代表某国际支付网络的风险投资部门处理其对一系列公司和平台进行的战略投资：<ul><li>某早期金融技术公司，包括应用于新加坡税务处理和缴费业务的B2B和B2C软件服务平台；</li><li>某开放式金融技术平台，为东南亚地区的金融机构提供解决方案；</li><li>在整个东南亚开展业务运营的印度尼西亚某B2C旅游服务平台。</li></ul></li><li>代表一家中国领先互联网服务公司处理对一家在香港和深圳的证券金融技术企业的多次债务及股权融资。这家证券金融技术企业提供用于在所选国际市场上交易股权的中文应用程序。</li><li>为科技、消费者健康、酒店等各种行业的数家跨国公司提供数据隐私和监管问题方面的法律建议。</li></ul>

Gigi Yuen

Of Counsel

Bryan’s practice focuses on advising both fund sponsors and investors in the formation and operation of private equity funds, venture capital funds, real estate funds, and other alternative investment products. Bryan also advises fund sponsors regarding related regulatory and internal governance matters. In addition, Bryan advises clients in private equity/M&A transactions and other related commercial transactions.Bryan is fluent in English, Cantonese, and Mandarin.Selected representations by Bryan include:<ul><li>Represented GLP Pte. Ltd. in connection with the establishment of GLP Japan Development Partners III, a Japan-focused logistics private real estate fund which is expected to reach JPY625 billion (US$5.6 billion) of assets under management when fully invested.</li><li>Represented a China-based investment bank in its joint venture with a Canada-based venture capital firm, and the establishment of a healthcare fund managed by the joint venture, with a fund size of the US$90 million, as well as related fund maintenance matters.</li><li>Represented an Asian sovereign wealth fund in connection with its investment in a $5 billion (target size) software-focused private equity fund sponsored by a leading U.S.-based manager.</li><li>Represented an Asian sovereign wealth fund in connection with its investment in a $3.5 billion (target size) private equity fund focused on growth equity and buyout investments sponsored by a leading U.S.-based manager.</li><li>Represented a U.S. technology company in connection with its investment in a $300 million clean energy-focused private investment fund sponsored by a leading asset management firm.</li></ul>

林上恩律师的业务重点是为基金发起人和投资者设立和运作私募股权基金、风险投资基金、房地产基金和其他另类投资工具、以及相关的监管和内部治理事宜提供法律服务。此外，林律师还为为客户提供私募股权/并购交易和其他相关商业交易方面的法律服务。林先生精通英语、粤语和普通话。

Bryan Lam

Winnie supports the Firm’s cross-border M&A, private equity transactions, venture capital financings, and general corporate and regulatory matters.She has also gained experience in fund formation and public company compliance matters during her training at the Firm.She is fluent in English, Cantonese, and Mandarin.<h4>Representative Experience</h4><ul><li>Ascendent Capital Partners in its US$1.66 billion privatization of Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), a leading international automation control system solutions provider.</li><li>Ascendent Capital Partners in its HK $360 million investment in China Automation Group Limited (SEHK.0569), provider of safety and critical control systems for the petrochemical, oil and gas, and railway industries, by way of an exchangeable bond, loan of which was provided to Araco Investment Limited, a shareholder of China Automation Group Limited.</li><li>Ascendent Capital Partners as an existing investor in a merger between NetDragon Websoft Holdings Limited (HKSE: 0777) and Mynd.ai, Inc. (NYSE: MYND). </li><li>A global education company in its acquisition by an Asia-headquartered private equity fund, of a majority stake for approximately US$700 million.</li></ul>

林律师协助本所的跨境并购、私募股权交易、风险投资融资、一般公司事宜和监管事宜。在本所实习期间，林律师还积累了处理基金设立和上市公司合规事宜方面的丰富经验。林律师精通英语、粤语和普通话。<h4>具有代表性的交易</h4><ul><li>代表上达资本处理其以16.6亿美元对和利时自动化科技有限公司（纳斯达克证券交易所股票代码：HOLI）进行私有化事宜。和利时自动化科技有限公司是一家领先的国际自动化控制系统解决方案提供商。</li><li>代表上达资本处理其向中国自动化集团有限公司（SEHK.0569）投资3.6亿港元的事宜。中国自动化集团有限公司是一家为石化、石油和天然气以及铁路行业提供安全和关键控制系统的提供商。该投资是以可换股债券的方式提供贷款给中国自动化集团有限公司的股东Araco Investment Limited。</li><li>就网龙网络控股有限公司（香港交易所股票代码：0777）与Mynd.ai, Inc.（纽交所股票代码：MYND）的合并事宜，向网龙现有股东上达资本提供了法律咨询。</li><li>代表一家全球教育公司处理其获某家以亚洲为总部的私募股权基金以约7亿美元收购其多数股权事宜。</li></ul>

Winnie Lam

Matthew’s practice focuses on the structuring of cross‑border M&A transactions and corporate reorganizations, particularly involving the United States, China, Japan, and the rest of the Asia‑Pacific region. He specializes in guiding clients through the intricacies of cross‑border transaction structures and intellectual property management from a tax perspective.Matthew has deep experience advising fund sponsors and institutional investors on tax issues relating to the formation of, and investments in, private equity funds, venture capital funds, real estate funds, and other alternative investment products. He has particular expertise in the U.S. taxation of government‑linked investors such as sovereign wealth funds and central banks.Matthew has represented multinational corporations and funds in transactions across more than 30 jurisdictions covering a wide range of industries, including technology, telecommunications, healthcare, real estate, consumer, media, and energy.Matthew is a Registered Foreign Lawyer with the Law Society of Hong Kong.While at Columbia Law School, Matthew was a three‑year Harlan Fiske Stone Scholar.

刘恩安（Matthew Lau）律师的业务侧重于跨境并购交易和企业重组的结构设计，特别是涉及美国、中国、日本和亚太地区其他国家的交易。他擅长从税务的角度协助客户处理复杂的跨境交易结构和知识产权管理。刘律师在为基金发起人和机构投资者就私募股权基金、风险投资基金、房地产基金和其他另类投资产品的成立和投资相关的税务问题提供法律咨询方面拥有丰富的经验。他尤其擅长处理美国对政府相关投资者（如主权财富基金和中央银行）的征税事宜。刘律师曾代表多家跨国公司和基金在30多个司法管辖区处理交易，涵盖科技、电信、医疗保健、房地产、消费品、媒体和能源等多个行业。刘律师是香港律师会注册外地律师。在美国哥伦比亚大学法学院就读期间，刘律师连续三年获得哈伦•菲斯克•斯通（Harlan Fiske Stone）奖学金。

Matthew Lau

Yilong’s practice focuses on mergers and acquisitions, private equity investments, as well as other general corporate matters.Yilong received a J.D. cum laude from Cornell Law School in 2017, where he was a notes editor of the Cornell Law Review.Yilong is a Registered Foreign Lawyer with the Law Society of Hong Kong. Prior to joining MoFo, he practiced in New York and London as an associate of two leading international firms. He is fluent in Mandarin and English.<h4>Representative Experience:</h4><ul><li>A leading private equity firm in its US$500 million partnership with Temasek, including Temasek taking a minority stake in the client, and a multi-fund investment by Temasek to anchor the client’s future funds.</li><li>A special purpose acquisition company in its US$300 million initial public offering and subsequent search for acquisition opportunities.</li><li>A U.S.-based pharmaceutical company in an up-C merger with Amneal Pharmaceuticals (NYSE: AMRX).</li><li>A leading private equity firm in its fund’s divestment of the majority of its holding in Orchid Orthopedic Solutions to Nordic Capital Fund IX.</li><li>A London-based family office in its strategic minority investments in EagleTree Capital.</li></ul>

罗亦龙律师的业务主要侧重于收购合并、私募股权投资，以及其他一般公司事宜。罗律师于2017年获得康奈尔大学法学院的法律博士学位，并以优等成绩毕业。他曾担任《康奈尔法律评论》的笔记编辑。罗律师是香港律师会注册外国律师。在加入美富前，罗律师曾分别在纽约与伦敦的两所顶尖国际律所担任律师。罗律师精通普通话与英语。<h4>具有代表性的项目：</h4><ul><li>代表某领先的私募股权公司处理其与淡马锡之间的5亿美元合作事宜，包括淡马锡收购其少数股权，以及淡马锡对多只基金作出投资，从而成为其未来基金的锚定投资者。</li><li>代表某特殊目的收购公司处理其3亿美元的首次公开发行，以及其后物色收购机会的事宜。</li><li>代表某位于美国的制药公司处理其与Amneal Pharmaceuticals（纽交所：AMRX）作出UP-C合并的事宜。</li><li>代表某领先的私募股权公司处理其设立的基金将其大部分Orchid Orthopedic Solutions的股权剥离并售予Nordic Capital Fund IX的事宜。</li><li>代表某位于伦敦的家族办公室处理其对EagleTree Capital作出战略性少数股权投资的事宜。</li></ul>

Yilong Luo

Ziqi’s practice focuses on private equity transactions, joint ventures, complex mergers and acquisitions, as well as other general corporate matters.Ziqi was a trainee solicitor in the Hong Kong office of Morrison & Foerster. She is fluent in English, Cantonese and Mandarin.<h4>Representative Experience</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>Ascendent Capital Partners, as a consortium member, in connection with the US$230.6 million privatization of Tarena International, Inc. (NASDAQ: TEDU), a leading professional education and K-12 education services provider in China.</li><li>Ascendent Capital Partners in its US$150 million investment in Best Assistant Education Online Limited (“Best Assistant”), an education business subsidiary of NetDragon Websoft Holdings Limited.</li><li>Ascendent Capital Partners on its three-tranche investment with a total value of US$500 million in the preferred shares of WM Tech Corporation Limited, the Cayman holding company of Wumei’s supermarket business, one of the largest supermarket chains and retailers in the PRC.</li><li>SoftBank Group Corp. and SoftBank Vision Fund in the US$40 billion sale of UK-headquartered multinational semiconductor and software design company Arm Limited to U.S. chip company NVIDIA (NASDAQ: NVDA).</li><li>SoftBank Vision Fund in connection with an investment totaling US$1.5 billion in Chehaoduo, a leading Chinese customer-to-customer auto retail services company that operates Guazi, an e-commerce platform focusing on second-hand car transactions, and Maodou, an e-commerce platform focusing on new car transactions.</li></ul>

漆子琪律师的执业领域主要涉及私募股权交易、合资企业、复杂并购，以及其他一般公司事宜。漆律师曾是美富香港办事处的实习律师。她精通英语、粤语和普通话。<h4>具有代表性的项目</h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>上达资本处理其与其他买方财团成员以2.306亿美元拟对达内时代科技集团有限公司（NASDAQ: TEDU）进行私有化的事宜。上达资本是买方财团成员之一。达内科技是中国顶尖的职业教育及K-12教育服务提供商。</li><li>上达资本处理其以1.5亿美元投资于Best Assistant Education Online Limited（“Best Assistant”）的事宜。Best Assistant为网龙网络控股有限公司旗下教育企业。</li><li> 上达资本处理其对WM Tech Corporation Limited的优先股进行三轮投资，总金额达5亿美元。WM Tech Corporation Limited是中国最大型连锁超市及零售商之一物美超市的开曼控股公司，并由物美科技集团有限公司（“物美”）控股。</li><li>软银和软银愿景基金处理其以400亿美元将总部位于英国的跨国半导体和软件设计公司安谋有限公司（Arm Limited）出售给美国领先的芯片公司英伟达（纳斯达克代码：NVDA）事宜。</li><li>软银愿景基金处理其对车好多集团总计15亿美元的投资。车好多是中国领先的汽车直卖平台，旗下主要包含瓜子二手车直卖网（主要经营二手车交易）和毛豆新车网（主要经营新车交易）两大平台。</li></ul>

Ziqi Qi

Gary’s practice focuses on investigation and dispute resolution matters for multinational and Asia-based companies. Gary has extensive experience in investigating allegations of corruption, fraud, conflict of interest, and other business misconduct in various industries including IT, finance, medical products, real estate, and manufacturing. He frequently assists multinational investors in pre-investment anti-corruption due diligence reviews of investments in China and other jurisdictions, as well as regulatory risk assessments of China business operations.   Gary also advises multinational companies in negotiating and litigating China-related business disputes. His experience includes assisting clients in connection with disputes arising out of Sino-foreign joint ventures, private antitrust enforcement, intellectual property, complex commercial contracts, and other business matters. In addition, he has extensive experience in assisting multinational companies in coordinating responses to Chinese regulatory inquiries.Gary is a Registered Foreign Lawyer with the Law Society of Hong Kong. Fluent in English, Mandarin, and Cantonese, he once worked as an in-house counsel for a major Fortune 500 company, advising on various contentious and regulatory matters in China.<h4>Representative Experience</h4><h5>Investigation/compliance</h5><ul><li>U.S. technology company in internal investigation of potential FCPA and corruption issues in China involving interactions with third party business consultants and Chinese government officials.</li><li>U.S. technology company in internal investigation of alleged bribery and fraudulent practices of senior management in China relating to sale of IT products through government procurement bids. </li><li>U.S. semiconductor company in internal investigation of potential FCPA and corruption issues in China, the U.S., and Europe involving cooperation with third party business consultants and interaction with Chinese state-owned enterprises.</li><li>Former senior executive of a major international investment bank in U.S. government investigations into hiring practices in Asia.</li><li>U.S. medical device company in M&A due diligence review of a China-based medical device company concerning anti-corruption internal controls and compliance with the FCPA and PRC anti-corruption laws.</li><li>Major U.S. private equity firm in pre-transaction FCPA and anti-corruption due diligence related to investment in a commercial real estate business in China. </li><li>Major international consulting company in M&A due diligence review of China-based companies concerning anti-corruption, internal controls, and compliance with PRC competition laws.</li><li>Two major international chemical companies in China compliance matters concerning environmental protection, product import, work safety, and other regulatory areas.  </li><li>Hong Kong listed Chinese companies in response to enquiries from Hong Kong regulatory authorities concerning operational and financial issues in mainland China. </li></ul><h5>Dispute Resolution</h5><ul><li>U.S. software company in a private anti-monopoly litigation alleging abuse of market dominance brought by former business partner in a PRC court.</li><li>Major Japanese chemical company in a Sino-foreign equity joint venture dispute with a Chinese SOE group concerning two joint venture companies in China. </li><li>U.S. technology company in connection with PRC court proceedings against Chinese distributor arising out of distribution of electrical equipment.</li><li>Leading Chinese financial database company in shareholder dispute and intellectual property-related dispute with U.S.-based minority shareholders.  </li><li>U.S. software company in a dispute with its China distributor and related internal investigation of alleged misconduct by the software company’s China managers.</li><li>U.S. software company in a computer software copyright infringement action against a Chinese company in a PRC court. </li><li>Major Chinese telecom company in a contractual dispute with business partners in the U.S. and China concerning complex telecom service contract performance issues.</li></ul>

曾宇律师的执业领域主要是为国际和亚洲公司处理与中国相关的调查和争议解决事宜。曾律师在处理调查事宜方面拥有丰富的经验，涉及反腐败、欺诈和其他业务不当行为主张的调查以及涉及信息技术、金融和制造等行业的调查。曾律师在协助跨国公司与中国监管机构的协调，并针对该类机构的质询做出答复以及处理其他争议及诉讼事宜方面也拥有丰厚的经验。他还拥有开展与合规问题相关的尽职调查工作的经验。在其职业生涯早期，曾律师在一家大型《财富500强》公司的中国公司担任两年多公司法律顾问。在担任公司法律顾问期间，针对各种争议和监管事宜提供法律意见。曾律师精通英语、粤语和普通话。他是香港律师会注册外国律师。

Gary Zeng

Yiman’s practice focus on internal investigation, white collar crimes, as well as regulatory matters.Yiman is experienced in handling internal investigations in connection with corruption, fraud, bribery and other business misconduct with a particular focus on China and the United States.She is fluent in Mandarin, English and Cantonese.<h4 dir="ltr">Representative Experience</h4><ul><li dir="ltr">A leading Fortune 50 life sciences company in multiple internal investigations regarding briberies of government officers and healthcare professionals, fraudulent sponsorship events and expense and fee for service-related issues in China.</li><li dir="ltr">A U.S.-listed chemical company in an internal investigation in connection to corruption and antitrust violations involving its distributors in China.</li><li dir="ltr">A U.S.-based equipment and software producer in an internal investigation regarding potential unauthorized diversion of products to institutions listed in the export control Entity list of the U.S. Department of the Commerce.</li><li dir="ltr">A U.S. software company in an internal investigation regarding alleged improper onboarding of a distributor in exchange for improper benefits in China.</li><li dir="ltr">A Swedish medical company in its internal investigation in connection to utilizing third-party distributors to funnel improper benefits including overseas trips and cash payments to healthcare professionals in China.</li></ul>

张律师的执业领域主要是内部调查、白领刑事以及监管事宜。张律师在处理与腐败、欺诈、贿赂和其他商业不当行为有关的内部调查方面经验丰富，尤其致力于处理在中国和美国进行的调查。张律师精通普通话、英语和粤语。<h4 dir="ltr">具有代表性的交易</h4><ul><li dir="ltr">代表一家领先的《财富50强》生命科学公司处理在中国进行的多项内部调查事宜。这些内部调查系关于贿赂政府官员和医疗专业人士、欺诈性赞助活动以及与费用及讲者费相关问题。</li><li dir="ltr">代表一家在美国上市的化学品公司处理内部调查事宜。此次内部调查系关于其中国经销商腐败和反垄断违规事宜。</li><li dir="ltr">代表一家美国设备和软件生产商处理内部调查事宜。此次内部调查系关于可能在未经授权的情况下将产品转至《美国商务部出口管制实体名单》中所列的机构。</li><li dir="ltr">代表一家美国软件公司处理内部调查事宜。此次内部调查系关于涉嫌在中国不当招募经销商以换取不当利益。</li><li dir="ltr">代表一家瑞典医疗公司处理内部调查事宜。此次内部调查系关于利用第三方经销商向中国医疗专业人士提供不当利益，包括海外旅行和现金付款。</li></ul>

Yiman Zhang

Sylvia’s practice focuses on fund formation and related matters. Sylvia regularly advises both managers and investors in the formation and operation of private equity funds, venture capital funds, real estate funds, and other alternative investment products, as well as related regulatory considerations. Sylvia is fluent in English, Cantonese, and Mandarin.<h4 dir="ltr">Representative Experience</h4><ul><li dir="ltr">GLP Pte. Ltd. (GLP), the leading global provider of modern logistics facilities and technology-led solutions, on the establishment of a US$5.6 billion Japan-focused logistics private real estate fund.</li><li dir="ltr">IndoSpace in connection with (i) the formation of IndoSpace Logistics Parks III, its US$580 million India-focused industrial real estate fund; and (ii) formation of IndoSpace Core, its US$1.2 billion joint venture with Canada Pension Plan Investment Board which will focus on acquiring and developing modern logistics facilities in India.</li><li dir="ltr">Savills Investment Management in connection with the formation of a US$500 million fund formed to invest in commercial real estate properties in Japan.</li><li dir="ltr">CBC Group (formerly C-Bridge Capital) in the formation of a US$300 million fund dedicated to investments principally in healthcare royalties and other cash flow assets that have a significant nexus to Greater China.</li><li dir="ltr">A leading diversified financial services company headquartered in Tokyo in the formation of a co-GP Cayman SPC targeting publicly offered real estate investment trusts (REITs) in China’s infrastructure.</li><li dir="ltr">Ping An, China Life, ICBC International and an Asian sovereigh wealth fund in connection with their respective investments in multiple private equity investment funds.</li></ul>

郑宝宜律师的执业范围主要为私募投资基金与相关事宜。郑律师经常为基金管理人和投资者提供私募股权基金、风险投资基金、房地产基金和其他替代投资产品的设立、运营和监管提供法律咨询服务。郑律师精通英语、粤语和普通话。<h4 dir="ltr">具有代表性的项目 </h4><ul><li dir="ltr">代表GLP Pte. Ltd（普洛斯）, 全球领先的现代物流设施及科技主导解决方案提供商, 处理其侧重于日本的56亿美元物流私募房地产基金成立事宜。</li><li dir="ltr">代表IndoSpace处理 i) 设立IndoSpace Logistics Parks III的事宜，IndoSpace Logistics Parks III是IndoSpace侧重于印度的5.8亿美元工业房地产基金；和 ii) 设立IndoSpace Core的事宜，IndoSpace Core是IndoSpace与加拿大养老金计划投资委员会成立的一家侧重于收购和开发印度现代物流设施的12亿美元合资公司。</li><li dir="ltr">代表第一太平戴维斯投资管理公司（Savills Investment Management）处理设立向日本商业房地产物业进行投资的5亿美元基金。</li><li dir="ltr">代表CBC集团（前身为C-Bridge Capital）处理设立3亿美元基金事宜，该基金主要致力于投资与大中华区有重要关系的医疗保健特许权使用费和其他现金流资产。</li><li dir="ltr">代表总部位于东京的某顶级多元化金融服务公司设立采用联席普通合伙人模式（co-GP）的开曼特殊目的公司，其主要投资对象为在中国基础设施领域公开发售的房地产投资信托基金（REIT基金）。</li><li dir="ltr">代表平安、中国人寿、工银国际和亚洲某主权财富基金处理其分别对多支私募股权投资基金进行的投资事宜。</li></ul>

Sylvia Cheng

Marcia Ellis is a Senior Counsel in our New York office and a Partner in our Hong Kong office. Marcia’s practice focuses on private equity transactions and complex mergers and acquisitions involving companies and other assets located in Asia. Having practiced in Asia for more than a quarter of a century, Marcia is one of the most experienced M&A lawyers active in the Asian market. In the past three years, she has advised clients on deals with a total aggregate value well in excess of US$249.8 billion.​Marcia regularly advises leading investors on M&A transactions, including SoftBank Vision Fund, Alibaba, GLP, Bain Capital, BlackRock, Farallon Capital, Ascendent Capital Partners, Silver Crest Acquisition Corp., PAG, Hillhouse, Hony Capital and Celadon Partners. In addition, she is experienced in representing U.S., UK and Asia based institutional investors in the acquisition, financing and disposition of real estate in China, Hong Kong and elsewhere in Asia, including numerous logistics and internet data center projects, and investment in and acquisition of real estate developers.From 2008 through 2011, she was the Chief Legal Officer for Asia of D. E. Shaw, where she assisted various group entities in making, restructuring, and exiting investments in various countries in Asia, including a number of significant and highly structured investments in China and India.Clients consider Marcia as a "super skilled technical lawyer" who offers "incredible problem-solving skills on all aspects of matters, both legal and commercial". A client said that "Finding a lawyer whose judgement you trust and who knows how far they can push the boundaries is not easy, and Marcia is the best lawyer I've worked with."Marcia is a member of our global board of directors and a member of our global Environmental, Social and Governance (ESG) Steering Committee. She served as a Global Co-Chair of the firm's Private Equity Practice. In 2022, she spearheaded the launch of MoFo’s annual survey of the ESG and DEI policies and practices of Asia-headquartered PE firms. She has also been named to Law360’s 2022 and 2023 Private Equity Editorial Board and elected as the Co-Chair of AmCham Hong Kong’s Women of Influence Committee. Marcia has been recognized as one of the Women of Influence in Private Markets: Private Equity by Private Equity International in 2024.

Marcia Ellis（艾琳）律师的执业重点是涉及亚洲境内公司和其它资产的私募股权交易和复杂并购。Ellis律师在亚洲执业超过二十五年，是活跃在亚洲市场经验最丰富的并购律师之一。在过去三年间，她为客户完成的交易的合计价值超过2498亿美元。Ellis律师经常为大型投资者提供并购交易法律咨询，这些投资者包括软银愿景基金、阿里巴巴、普洛斯、Bain Capital、贝莱德、Farallon Capital、上达资本、Silver Crest特殊目的收购公司、PAG、高瓴资本、弘毅投资以及Celadon Partners。此外，在代表美国、英国、亚洲机构投资人方面她也富有经验；她代表客户处理收购、融资、处置中国、香港及亚洲其它地区的房地产，其中包括许多物流和互联网数据中心项目，也处理对房地产开发商的投资与收购。从2008至2011年，Ellis律师是德劭集团亚洲区的首席法务官。在德劭集团，她协助各集团实体处理在亚洲多个国家进行的投资、投资重组及投资退出事宜，包括在中国和印度进行的多个重要及高度结构化的投资。客户评价Ellis律师是一位"技巧高超的律师"，她拥有 "极其出色的解决问题的能力，包括法律问题和商业问题 "。一位客户称："找到一位拥有令人信任的判断力，并能尽力突破极限的律师并不容易，而她是我合作过的最好的律师"。Ellis律师是美富律师事务所的全球董事会成员，兼本所全球环境、社会与治理(ESG)指导委员会委员之一。她曾任本所的全球私募股权业务联席主席。在2022年，她率先发起了美富对总部位于亚洲的私募股权公司的环境、社会与治理以及可持续性的政策与实践的年度调查。她还当选《法律360》(Law 360)2022年度和2023年度私募股权业务编辑委员会成员，以及香港美国商会最具影响力女性(WOI)指导委员会联席主席。Ellis律师还荣获Private Equity International评为2024年“私募股权领域：私募市场最具影响力女性”之一。

Marcia Ellis

Senior Counsel (New York) | Partner (Hong Kong)

Harriet’s practice focuses on fund formation and related matters.Harriet supports the private funds team in the formation and operation of private equity funds, venture capital funds, real estate funds, and other alternative investment products, as well as related restructuring, regulatory, and internal governance matters.Harriet is fluent in English, Cantonese, and Mandarin.<h4>Representative Experience</h4><ul><li>A major international insurance company and its affiliates in their LP investments in various leading private blind-pool funds and single-asset co-investment funds across several industries and strategies, including infrastructure and logistics, with capital commitments aggregating to more than US$1 billion.</li><li>One of the largest insurance companies headquartered in Hong Kong with respect to its investment in multiple private equity investment funds.</li><li>The asset management platform of a global investment bank on the ongoing fund management and compliance matters relating to its PRC funds.</li><li>An Asia sovereign wealth fund in connection with its investment in a private equity fund with a focus on healthcare and financial services sectors in Asia and Africa.</li><li>A Singapore-based fund management company of a fund dedicated to investing in advanced medical devices, precision healthcare services, and innovative pharmaceutical sectors, with a strategic focus on emerging markets across Southeast Asia, Central Asia, and the Gulf Cooperation Council countries.</li></ul>

何律师的执业领域主要是基金设立和相关事宜。  何律师协助私募基金团队处理私募股权基金、风险投资基金、房地产基金及其他另类投资产品的设立和运营事宜，以及相关重组、监管及内部治理事宜。何律师精通英语、粤语和普通话。<h4>具有代表性的项目</h4><ul><li>代表一家大型国际保险公司及其关联方处理其对多个领先的私募盲池基金及单一资产共同投资基金进行的有限合伙人投资事宜。这些基金涵盖多个行业和策略（包括基础设施和物流），累计资本承诺额超过10亿美元。</li><li>代表某香港最大的保险公司之一处理其对私募投资基金进行投资的法律事宜。</li><li>代表一家全球投资银行的资产管理平台处理与其中国基金有关的日常基金管理及合规事宜。</li><li>代表一家亚洲主权财富基金处理其向一支致力于亚洲和非洲医疗保健和金融服务行业的私募股权基金进行投资事宜。</li><li>代表一家位于新加坡的基金管理公司设立一支专注于投资先进医疗器械、精准医疗保健服务和创新型医药行业的基金，其战略重点是东南亚、中亚以及海湾合作委员会国家等新兴市场。</li></ul>

Harriet Ho

Kristen’s practice focuses on IP litigation and post-grant strategy and disputes. She has litigated a wide range of high-technology cases for U.S. and non-U.S. based clients in U.S. federal courts and before the International Trade Commission.Her experience includes drafting briefs, handling all aspects of discovery, including drafting expert reports and declarations, deposition and trial preparations, and trials. The technologies at issue in her matters have spanned areas such as computer software, semiconductors, image/video processing, smart devices, and medical devices.Kristen is fluent in English, Cantonese, and Mandarin.

黎律师的执业领域主要是知识产权诉讼以及专利授权后策略和争议解决事宜。她曾就各种高科技领域的案件为美国和非美国客户在美国联邦法院和美国国际贸易委员会处理诉讼事宜。黎律师的经验包括起草法律文书、处理证据开示所涉及的各方面事宜，包括起草专家报告和声明、庭外取证（deposition）与庭审准备及庭审等工作。黎律师处理的案件所涉技术领域广泛，包括计算机软件、半导体、图像/视频处理、智能设备以及医疗器械等。黎律师精通英语、粤语和普通话。

Kristen Lai

Paul has more than 30 years’ experience advising leading international companies on complex transactional and other business law matters in China and elsewhere in Asia.He advises Fortune 100 and other global companies pursuing M&A, joint venture, and other corporate transactions, bringing to his work a deep understanding of the regulatory environment in China and a sensitivity to cultural issues in Asia. Paul also helps clients navigate China’s complex and changing regulatory environment, advising on a broad range of issues such as data privacy and security, industry permitting, and anti-corruption compliance. Paul is a member of the firm’s market-leading global data, cyber and privacy group and a recognized expert on China’s emerging data regulatory regime. He works across a broad range of industries, including information technology, real estate, chemicals and energy, and natural resources.Paul is a fluent Mandarin speaker and has written widely on issues related to Chinese law.He serves on the board of directors of The Morrison & Foerster Foundation, the firm’s charitable foundation.

麦保罗（Paul McKenzie）律师在代表领先的国际公司处理中国和其他亚洲地区的复杂交易和其他商业法律事宜方面拥有超过30年的经验。麦保罗律师代表财富100强企业和其他全球公司处理并购、合资和其他公司交易事宜，同时将他对中国监管环境的深入了解，以及对亚洲文化问题的敏锐运用于其中。他还帮助客户应对中国复杂且不断变化的监管环境，并就各类问题（例如数据隐私与网络安全，行业许可和反腐败合规）提供咨询。麦保罗律师还是本所市场领先的全球隐私和数据安全业务组的成员之一，也是中国新兴数据监管制度领域公认的业内专家。麦保罗律师的业务涉及广泛的行业，包括信息技术，房地产，化学品，能源和自然资源。他精通汉语，并针对中国法律的相关问题广泛撰文。麦保罗律师是本所的慈善基金 “美富基金会”的董事会成员。

Paul McKenzie

Liam’s practice focuses on cross-border dispute resolution, regulatory compliance, sanctions, and white-collar crime investigations under the U.S. Foreign Corrupt Practices Act (FCPA).He has also gained experience in private equity transactions, mergers and acquisitions, and venture capital financings, as well as other general corporate matters during his training at the firm.Liam is fluent in English and Mandarin Chinese.<h4>Representative Experience</h4><ul><li>A leading Fortune 100 life sciences company in multiple internal investigations across Mainland China and Taiwan, involving: (1) bribery of government officials and healthcare professionals, (2) fraudulent sponsorships and fee-for-service arrangements, (3) fraudulent research grants, (4) misuse of patient assistance programs and charitable drug assistance programs, (5) improper collection of sensitive patient information and prescription data, (6) improper selection and onboarding of distributors presenting conflict-of-interest risks, (7) unauthorized use of third-party tools for business purposes, and (8) T&E-related issues.</li><li>A publicly listed global gaming platform in an internal investigation involving allegations of corruption and conflict of interest issues related to its hiring practices in China, with cross-border elements in the United States.</li><li>A leading global technology company in connection with: (1) product safety investigations conducted by Hong Kong authorities; (2) regulatory approval and rollout of new electronic products; and (3) other routine compliance advisory work, including product advertisement, waste disposal, trade description, credit card fraud, and network offering, etc.</li><li>A leading global technology company in various consumer claims in the Hong Kong courts, including the District Court, the High Court, and the Small Claims Tribunal (SCT). The issues involved include property loss, privacy breaches, and personal injury.</li><li>The ultimate beneficial shareholder of a Seychelles company in navigating parallel proceedings across jurisdictions including Mainland China, Hong Kong, Singapore, and Seychelles.</li><li>A U.S. biotechnology startup in an expedited SIAC arbitration proceeding concerning a contractual dispute against an established multinational contract development and manufacturing organization. The dispute arose out of a Development and Manufacturing Services Agreement and involved cross-claims for delay and performance-related damages. </li></ul>

邵涵律师的执业范畴主要包括跨境争议解决、监管合规、制裁以及根据美国《反海外腐败法》（FCPA）开展的白领罪案调查。在本所见习期间，他还积累了私募股权交易、并购、风险投资融资以及其他一般公司事务方面的经验。邵律师精通英文和中文。<h4>具有代表性的项目</h4><ul><li>代表一家领先的《财富100强》生命科学公司处理在中国大陆及台湾地区进行的多项内部调查事宜。这些内部调查涉及（1）向政府官员及医疗卫生专业人士行贿；（2）虚假赞助及讲者服务费安排；（3）虚假科研资助项目；（4）患者援助项目的滥用；（5）不当收集敏感患者信息及医生处方数据；（6）存在利益冲突风险的经销商遴选及准入；（7）未经授权使用第三方工具开展业务活动；以及（8）差旅及业务招待费用（T&E）相关问题。</li><li>代表一家上市的全球游戏平台处理内部调查事宜。该调查涉及对其在中国的、含美国跨境因素的雇佣行为涉嫌腐败和利益冲突进行的指控。</li><li>代表一家全球领先的科技公司处理以下事宜：（1）香港监管机构开展的产品安全调查；（2）新电子产品的监管审批及市场投放；（3）其他日常合规咨询工作，包括产品广告、废弃物处置、商品说明、信用卡欺诈以及网络服务提供等。</li><li>代表一家领先的全球科技公司处理香港法院的各种消费者索赔事宜，包括区域法院、高等法院以及小额钱债审裁处（SCT），当中涉及的法律问题包括财产损失、隐私侵犯和人身伤害等。</li><li>代表一家塞舌尔（Seychelles）公司的最终实益股东应对在包括中国大陆、香港地区、新加坡和塞舌尔在内的多个司法管辖区进行的平行诉讼程序。</li><li>代表一家美国生物技术初创公司处理由新加坡国际仲裁中心处理的快速仲裁事宜。此次仲裁系关于针对一家知名跨国合同研发与制造机构提起的合同争议。争议源于一份《研发与制造服务协议》，涉及因延误及履约相关损害赔偿而提出的交叉索赔。</li></ul>

Liam Shao

Tyler’s practice encompasses various aspects of transactional, regulatory, and contentious IP matters including technology transfer and licensing, IP and data-driven strategic cooperation, technical services and outsourcing arrangements, technology/IP-related advice in cross-border M&A and PE transactions, cybersecurity and data privacy, telecommunications regulation, pharmaceutical regulation, and patent protection. He advises a diverse range of multinational companies mainly in the life sciences, IT, telecommunications, manufacturing, and financial industries. In the words of his clients, “Tyler Xiu is an excellent up-and-coming lawyer, who is very proactive and helpful.” (The Legal 500 Asia Pacific).Tyler is fluent in Chinese and English.<h4>Representative Experience</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>Advising Ensem Therapeutics, Inc., a biotechnology company focusing on high value and difficult-to-drug oncology targets, on its partnership with BeiGene, Ltd., a global biotechnology company, for BeiGene to acquire an exclusive global license to an Investigational New Drug (IND) application-ready oral cyclin-dependent kinase 2 (CDK2) inhibitor. Under the terms of the agreement, ENSEM will receive an upfront payment, and will be eligible for additional payments upon the achievement of certain development, regulatory, and commercial milestones, totaling up to $1.33 billion, in addition to tiered royalties.</li><li>Advising Jamieson Laboratories Ltd. and its parent company Jamieson Wellness Inc. (TSX:JWEL) in their partnership with DCP Capital, a leading international private equity firm founded by experienced private equity investors in Greater China. Through this transaction, DCP contributed US$35 million in exchange for a 33% interest in the Company’s Chinese operations and made a US$75 million preferred share investment in the Company.</li><li>Counseling a U.S. medical device company that focuses on the research, development, production, and marketing of respiratory care devices and services, in its engagement by a PRC medical device company for commissioned development of automatic high flow ventilators, including the associated technology licensing arrangements.</li><li>Advising a U.S. biopharmaceutical company on its strategic collaboration with a Chinese pharmaceutical company to develop and commercialize a bi-functional fusion protein inhibiting immune checkpoint and activating natural killer (NK) cells for the treatment of solid tumors, in the Asia Pacific Ex-Japan region.</li><li>Advising a leading pan-Asian retailer in Hong Kong on:<ul><li>A technology license agreement and joint venture with a digital retail platform for the purposes of providing online retailers with operational processes, marketing, supply, payment, merchandise, e-commerce, and customer services; and</li><li>Its licensing of technology and trademarks and provision of technical services in relation to the establishment of a joint venture for the purposes of developing a market-leading independent multi-partner coalition loyalty program for the ASEAN markets, and also the data privacy and data security issues under PRC law and cross-border data transfer issues that involve multiple jurisdictions in Asia. </li></ul></li><li>Advising an online game platform and game creation system on its trailblazing joint venture with another company to establish and launch the game platform in China, which would be the first foreign online game platform with user-generated games and revenue-sharing to obtain a government license in the PRC. </li><li>Advising a leading Chinese investment fund on its strategic partnership with a leading U.S. IT software company to establish the financial cloud infrastructure for the People’s Bank of China, key state banks, and the governments of various major cities.</li><li>Assisting a leading global digital library with the amendment of its license agreement with a Chinese Internet technology company, under which the tech company is granted a license to allow users to access the client’s digital library of sheet music.</li><li>Advising a PRC advanced semiconductor materials company on obtaining a technology license and associated support services from a German specialty chemicals and equipment company, with respect to chemicals for wafer level packaging and wafer level semiconductor interconnect.</li></ul>

修徇泽律师擅长处理知识产权项目所涉及的交易、监管、争议解决等多个层面的法律问题，包括技术转让和许可、知识产权及数据驱动的战略合作、技术服务和外包、跨境并购/私募股权交易所涉及的技术及知识产权问题、网络安全及数据隐私保护、电信监管，药品监管、以及专利保护等。修律师主要为生命科学、信息技术、电信、制造和金融行业的跨国客户提供法律意见。客户曾如此评价他：“修律师是一位崭露头角的出色律师，他非常积极主动，提供富有成效的建议。”（《亚太法律500强》）修律师精通中英文。<h4>具有代表性的项目 </h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>代表聚焦肿瘤治疗领域高价值、难成药靶点的生物科技公司昂胜医药(Ensem Therapeutics, Inc.)达成一项与全球生物科技公司百济神州(BeiGene, Ltd.)的授权合作协议。百济神州将获得一款在研、即将提交新药临床试验(IND)申请的口服细胞周期蛋白依赖性激酶2(CDK2)抑制剂的全球独家许可权利。根据协议条款，昂胜将获得一笔首付款，并基于取得的特定研发、注册和商业化里程碑，有权获得至多13.3亿美元的总交易额款项，以及分级销售特许使用费。</li><li>代表Jamieson Laboratories Ltd.及其母公司健美生公司（多伦多证券交易所：JWEL）处理其与DCP Capital达成合作的事宜。DCP Capital是一家由大中华区经验丰富的私募股权投资者所创立的领先的国际私募股权公司。通过本次交易，德弘出资3500万美元，获得该公司中国业务33%的权益，并以优先股形式对该公司进行7500万美元的投资。</li><li>代表一家专注于研究、开发、生产和销售呼吸护理设备和服务的美国医疗设备公司处理其受一家中国医疗设备公司委托开发自动高流速呼吸机的事宜，包括相关的技术许可安排。</li><li>代表美国某生物制药公司与一家中国制药公司进行战略合作，在除日本外的亚太地区开发和商业化一种抑制免疫检查点和激活自然杀伤细胞治疗实体瘤的双功能融合蛋白的事宜。</li><li>代表一家位于香港的领先的泛亚洲零售商： </li><ul><li>处理其与一家数字零售平台签订技术许可协议并成立合资企业，为在线零售商提供运营流程、营销、供应、支付、商品、电子商务和客户服务；以及</li><li>成立一家合资企业，并向该合资企业授权技术和商标并提供技术服务，以便在东盟市场开发市场领先的独立多合作伙伴联盟忠诚度计划。同时处理涉及中国法律规定的数据隐私和数据安全问题，以及涉及亚洲多个司法管辖区的跨境数据传输问题。</li></ul><li>代表一家网络游戏平台和游戏创作系统公司处理其与另一家公司成立合资企业，在中国建立并推出游戏平台，该游戏平台将成为首个在中国获得政府许可的用户生成游戏和收入共享的外国网络游戏平台。</li><li>代表一家领先的中国投资基金处理其与一家领先的美国IT软件公司建立战略合作伙伴关系，为中国人民银行、主要国有银行和各大城市政府建立金融云基础设施。</li><li>代表某全球领先的乐谱数字图书馆处理其与某中国互联网科技公司修改许可协议的事宜。依据该许可协议，该科技公司被授予许可允许其用户访问乐谱数字图书馆。</li><li>代表一家中国先进的半导体材料公司处理其从一家德国特殊化学品和设备公司获得技术许可和相关支持服务的事宜，其中涉及晶圆级封装和晶圆级半导体互连的化学品。</li></ul>

Tyler Xiu

Shuwen advises leading banks and financial institutions, private equity sponsors, alternative financiers, and strategic borrowers on cross-border financing work, including leveraged and acquisition finance, bilateral and syndicated loans, and debt restructuring transactions.Shuwen is a Registered Foreign Lawyer with the Law Society of Hong Kong. Prior to joining Morrison Foerster, she worked at the Hong Kong office of a leading international law firm. She is fluent in English, Mandarin, and Cantonese.